COX-2 independent induction of cell cycle arrest and apoptosis in colon cancer cells by the selective COX-2 inhibitor celecoxib

FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
S GröschG Geisslinger

Abstract

The regular use of various nonsteroidal anti-inflammatory drugs (NSAIDs) was shown to decrease the incidence of colorectal cancer. This effect is thought to be caused predominantly by inhibition of cyclooxygenase-2 (COX-2) and, subsequently, prostaglandin synthesis. However, recent studies have suggested that COX-independent pathways may contribute considerably to these antiproliferative effects. To evaluate the involvement of COX-dependent and COX-independent mechanisms further, we assessed the effects of celecoxib (selective COX-2 inhibitor) and SC560 (selective COX-1 inhibitor) on cell survival, cell cycle distribution, and apoptosis in three colon cancer cell lines, which differ in their expression of COX-2. Both drugs induced a G0/G1 phase block and reduced cell survival independent of whether or not the cells expressed COX-2. Celecoxib was more potent than SC560. The G0/G1 block caused by celecoxib could be attributed to a decreased expression of cyclin A, cyclin B1, and cyclin-dependent kinase-1 and an increased expression of the cell cycle inhibitory proteins p21Waf1 and p27Kip1. In addition, celecoxib, but not SC560, induced apoptosis, which was also independent of the COX-2 expression of the cells. In vivo, celecoxib ...Continue Reading

References

Jan 1, 1992·Cytometry·Z DarzynkiewiczF Traganos
Jan 1, 1995·American Journal of Obstetrics and Gynecology·D M SlaterP R Bennett
Mar 1, 1994·Molecular and Cellular Biology·H MatsushimeJ Y Kato
Mar 1, 1994·Molecular and Cellular Biology·M Meyerson, E Harlow
Dec 24, 1993·Science·S van den Heuvel, E Harlow
Mar 26, 1993·Science·M Ohtsubo, J M Roberts
Jun 18, 1993·Cell·C J Sherr
May 1, 1997·The Journal of Clinical Investigation·H ShengR N DuBois
Jan 1, 1997·Advances in Pharmacology·W E Smalley, R N DuBois
Jun 10, 1997·Proceedings of the National Academy of Sciences of the United States of America·M FiscellaE Appella
Apr 9, 1998·International Journal of Cancer. Journal International Du Cancer·L QiaoB Rigas
Oct 28, 1998·Proceedings of the National Academy of Sciences of the United States of America·C J SmithP C Isakson
Dec 22, 1999·Oncogene·M Barkett, T D Gilmore
Mar 10, 2000·Advances in Experimental Medicine and Biology·G D StonerR U van Stolk
Mar 10, 2000·Advances in Experimental Medicine and Biology·B Rigas, S J Shiff
Mar 16, 2000·Journal of Chromatography. B, Biomedical Sciences and Applications·M J RoseB K Matuszewski
Jun 30, 2000·The New England Journal of Medicine·G SteinbachG Kelloff
Feb 13, 2001·The Journal of Clinical Investigation·A S Baldwin
May 12, 2001·The Breast Journal·Eleanor E. R. Harris, Lawrence J. Solin
Jun 28, 2001·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·E NiederbergerG Geisslinger

❮ Previous
Next ❯

Citations

Aug 25, 2005·Journal of Huazhong University of Science and Technology. Medical Sciences = Hua Zhong Ke Ji Da Xue Xue Bao. Yi Xue Ying De Wen Ban = Huazhong Keji Daxue Xuebao. Yixue Yingdewen Ban·Juan DingShusheng Gong
Dec 22, 2010·Naunyn-Schmiedeberg's Archives of Pharmacology·Jang-Shiun WangKuo-Chin Huang
Apr 13, 2007·Cancer Chemotherapy and Pharmacology·Bassel F El-RayesPhilip A Philip
Apr 17, 2010·International Journal of Colorectal Disease·Ioannis A VoutsadakisChristos N Papandreou
Feb 5, 2013·Cellular Oncology (Dordrecht)·Seung Won KimJae Hee Cheon
Jun 1, 2005·Biochimica Et Biophysica Acta·Tong Wu
Dec 4, 2003·Biochemical and Biophysical Research Communications·Frantzy EtienneHerbert Weissbach
Oct 27, 2004·Critical Reviews in Oncology/hematology·J B TuynmanD J Richel
Jan 31, 2004·International Journal of Radiation Oncology, Biology, Physics·Eiko NakataLuka Milas
Jan 31, 2004·International Journal of Radiation Oncology, Biology, Physics·Claus BelkaWilfried Budach
Jul 19, 2005·Journal of Hepatology·Lucrecia Márquez-RosadoSaúl Villa-Treviño
Nov 16, 2002·Prostaglandins & Other Lipid Mediators·Naoki KawaiShingo Tsuji
Oct 14, 2003·The Lancet Oncology·Giampietro GaspariniAlessandro Morabito
Aug 30, 2003·International Immunopharmacology·Toru KimuraMasao Nagumo
Oct 22, 2003·Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver·B BuecherH M Blottière
Oct 18, 2008·The Kaohsiung Journal of Medical Sciences·Wen-Chun Hung
Dec 2, 2004·Journal of the National Cancer Institute·Xiangguo LiuShi-Yong Sun
Jun 8, 2006·Journal of the National Cancer Institute·Sabine GröschGerd Geisslinger
Feb 18, 2012·Pharmacogenetics and Genomics·Li GongTeri E Klein
Oct 1, 2008·Journal of Gastroenterology and Hepatology·Nayoung KimIn Sung Song
Feb 26, 2013·Journal of Clinical Pathology·Sandra A O'TooleSamantha R Oakes
Dec 17, 2008·Molecular Cancer Therapeutics·Seong-Ho LeeSeung Joon Baek
Nov 18, 2011·Lipids in Health and Disease·Paul L WoodDayan B Goodenowe
Jun 9, 2009·PloS One·Maria MarchettiDavid Binninger
Dec 19, 2013·PloS One·Alessandra Di PentaKoen Vandenbroeck
Feb 22, 2011·Journal of the American Society of Nephrology : JASN·Qian ZhangJing Chen
Feb 23, 2011·International Journal of Molecular Sciences·Wei LiLing-Yun Zhai
Dec 4, 2012·International Journal of Molecular Sciences·Jean Leandro Dos SantosChung Man Chin
Mar 8, 2012·Future Medicinal Chemistry·Leyte L Winfield, Florastina Payton-Stewart
Feb 9, 2005·Proceedings of the National Academy of Sciences of the United States of America·Siva Kumar KolluriXiao-kun Zhang
Mar 4, 2014·Der Anaesthesist·A BundschererB M Graf
Feb 13, 2014·Cancer Research and Treatment : Official Journal of Korean Cancer Association·Hee Jung KimYoung Tae Kim
Mar 30, 2007·Digestive Diseases and Sciences·Soo-Jeong ChoIn Sung Song

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cell Checkpoints & Regulators

Cell cycle checkpoints are a series of complex checkpoint mechanisms that detect DNA abnormalities and ensure that DNA replication and repair are complete before cell division. They are primarily regulated by cyclins, cyclin-dependent kinases, and the anaphase-promoting complex/cyclosome. Here is the latest research.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Cell Cycle Pathways

Cell cycle is a complex process regulated by several signal transduction pathways and enzymes. Here is the latest research on regulation of cell cycle and cell cycle pathways.